Innovative Presentation of LACRIFILL Canalicular Gel at SECO 2025
Exciting Developments in Dry Eye Treatment
Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., is set to make waves in the optometric field with a significant poster presentation at the upcoming SECO 2025 conference. This event is being held in a prominent city, bringing together the brightest minds in optometry to share the latest advancements in eye care.
The Focus of the Presentation
The highlight of the presentation revolves around the innovative LACRIFILL Canalicular Gel, a cutting-edge hyaluronic acid gel designed for a unique application method. It is delivered through a pre-loaded syringe directly into the canaliculus to treat dry eye symptoms effectively. This presentation will provide insights into a case series involving three patients suffering from refractory dry eye disease who experienced notable improvements after using the gel.
Expert Testimony and Results
OD Mile Brujic from Premier Vision Group shares firsthand experiences highlighting the positive outcomes of the treatment. He emphasizes the significant improvement in comfort and corneal health observed in his patients. According to Brujic, this novel treatment has not only enhanced patient satisfaction but also allowed him to expand his practice's offerings thanks to the efficacy of LACRIFILL Canalicular Gel.
About SECO International
SECO International stands as one of the world’s largest optometric educational conferences, showcasing groundbreaking research and innovations. Attendees are thrilled to explore the latest practices and products that aim to enhance patient care, presenting companies like Nordic Pharma with opportunities to connect with eye care professionals across the globe.
The Future of LACRIFILL Canalicular Gel
Phil Gioia, President of the U.S. team at Nordic Pharma, expresses enthusiasm about the role that optometrists play in administering LACRIFILL Canalicular Gel. He points out the ongoing partnerships with eye care professionals since the product's launch, further reinforcing the commitment to enhancing the management of dry eye conditions.
Event Details
Details of the presentation are as follows:
Title: Novel Canalicular Gel for Lacrimal Occlusion: Case Series
Author: Mile Brujic, OD, FAAO
Date & Time: Late February, approximately 9:45 AM – 11:45 AM
Venue: Georgia World Congress Center, showcasing the latest in optometric technology.
Post-Conference Accessibility
For those unable to attend, the posters will be made available online after the event, ensuring that all interested parties can access the findings shared during this conference.
About Nordic Group B.V.
Nordic Group B.V. prides itself on being a dynamic international pharmaceutical company. With a core focus on developing specialized products, it has carved out a substantial niche in Eye Care, Rheumatology, and Women's Health sectors. Through strategic acquisitions and dedicated development, Nordic Group B.V. has expanded its influence beyond its original geographical focus to a global scale.
About Nordic Pharma, Inc.
As part of Nordic Group B.V., Nordic Pharma, Inc. joins forces with prominent global biopharmaceutical entities, leveraging its advanced capabilities to introduce innovative, biotechnology-derived medical solutions. Their commitment to advancing sterile manufacturing and state-of-the-art technologies underscores their role in the evolving pharmaceutical landscape.
Frequently Asked Questions
What is LACRIFILL Canalicular Gel?
LACRIFILL Canalicular Gel is a hyaluronic acid gel designed to treat dry eye symptoms by occluding the canaliculus.
Who presented the case series at SECO 2025?
The case series was presented by Mile Brujic, OD, FAAO from Premier Vision Group.
What were the results of the case series?
The case series showed significant improvements in symptoms and comfort for three patients with refractory dry eye disease.
Where and when was the presentation held?
The presentation took place at the Georgia World Congress Center during SECO 2025, with a specific time scheduled in late February.
How can I learn more about LACRIFILL Canalicular Gel?
For more detailed information, visit the official website dedicated to LACRIFILL products.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
